Grand Rounds Recap 8.9.23

R1 CK: Pericarditis & myocarditis - r3 taming the sru - r4 case follow-up - ent emergencies - Ortho in a Resource-limited setting - pharmacy updates - pediatric seizures


R1 Clinical knowledge: Pericarditis and Myocarditis WITH Dr. Knudsen-Robbins

  • Overall, maintain a high index of suspicion, much of work-up is non-specific

  • Pericarditis:

    • EKG: diffuse ST elevations, Spodick's sign, also can be normal

    • Dx need 2/4: typical pain, EKG, new/worsening effusion, friction rub

    • If arrhythmias - consider concomitant/alternate pathology

    • If trop elevated - consider concomitant myocarditis

    • Mostly viral but also consider TB, neoplastic, systemic or autoimmune disease

    • Likely acute viral can go home on NSAID’s and colchicine if no high-risk features

  • Myocarditis

    • Exam: tachycardia out of proportion to fever

    • EKG: sinus tach, global findings, block, fragmented QRS

    • Echo: normal, global findings, regional wall motion abnormalities, enlarged wall/septum

    • Admit


Taming the SRU WITH Dr. Harward

  • Resource mobilization and team preparation are essential components of any complex resuscitation

  • Basic tenets of resuscitation are universal: airway, breathing, circulation (the air goes in & out, the blood goes round & round...)

  • Left ventricular assist devices (LVAD’s) mechanically augment left ventricular function

    • some patients retain enough native function to have a palpable pulse -- conventionally measured BP is reliable in these patients

    • hemodynamic stability is best assessed by MAP in patients without a palpable pulse

    • clinical indicators of perfusion (mental status, capillary refill, cyanosis) are the best way to rapidly assess hemodynamic stability if quantitative measures are not available

  • Chest compressions can be safely performed in patients with implanted LVAD’s

    • there is a theoretical risk of displacing the LVAD with chest compressions, but (limited) available evidence suggests this is not common

    • clinically significant aortic regurgitation develops or progresses in 10% of LVAD patients -- a minority of these patients will have their aortic valves partially or completely oversewn with coaptation sutures

    • withholding cardiopulmonary resuscitation will always result in the death of your patient

  • LVAD-specific complications include suction events & VAD thrombosis

    • suction events occur with loss of left ventricular preload and may result in ventricular arrythmias; these correct with GENTLE fluid resuscitation (straight leg raise, 250mL bolus)

    • LVAD thrombosis may affect the inflow/outflow cannulae or the LVAD pump itself and are highly lethal; patients should be anticoagulated at all times


r4 Case FOllow-up WITH Dr. Gillespie

  • Communication strategies in taking a history are just as important as understanding the way laboratory tests work in interpreting “data” in patient care. Approach your word choice and angle in obtaining a history and learning a patient story as you would in choosing a diagnostic test (ex. CT head versus CTA); different questions beget different stories.

  • Patients may come from different perspectives, backgrounds, communication styles, environment interpretations, cognitive biases. A patient perspective may be presented differently or at times, be difficult to tease out, however often contains key data that may be disguised. Recognize there is often “signal” in the noise.

  • We all carry cognitive biases and heuristics that modify the interpretation of our surroundings and the information we obtain and analyze. Recognizing the personal factors you carry into interpreting information can equip you to become a more informed analyst.


Community corner: ENT Emergencies WITH dr. Lafollette

  • Quincke’s Edema

    • Isolated uvular angioedema

      • rare presentation of angioedema

      • likely a histamine-mediated allergic angioedema (aka type I hypersensitivity reaction)

    • Management

      • antihistamine/H2 blocker/steroid administration

      • stop offending ACE-I/ARB

      • period of observation

      • discharge w/ allergist follow-up

  • Complex Facial Lacerations

    • Consider anesthesia

      • including need for nerve blocks

    • Extensive irrigation

    • Examine need for muscle layer repair

      • such as inability to wrinkle forehead

    • Layered repair is usually best

    • Update tetanus vaccine

    • Discharge on antibiotics and plans for outpatient follow-up

  • Lemierre’s Disease

    • Form of thrombophlebitis involving the internal jugular vein thrombosis

      • typically caused by Fusobacterium necrophorum

    • Seen in younger, healthy patients with history of recent oropharyngeal infection

      • typically recent bout of Strep pharyngitis

    • Presentation typically involves prolonged sore throat and fevers, usually for 1-2 weeks after initial symptom onset

      • expect lymphadenopathy and painful neck on exam

    • Diagnosis involves CT of the neck with IV contrast

    • Management

      • antibiotics with anaerobic coverage

        • such as unasyn or zosyn for several weeks

  • Acute Dental Fractures

    • Management based on Ellis classification

      • Class I (enamel only)

        • dental referral

      • Class II (enamel + dentin)

        • expect to see yellow dentin on exam

        • coverage with calcium hydroxide paste

        • consider antibiotics

        • urgent dental referral

      • Class III (enamel + dentin + pulp)

        • expect to see pink pulp/bleeding on exam

        • coverage with calcium hydroxide paste

        • add antibiotics

        • emergent dental/oral surgery referral (need to be seen within 24h of leaving the ED)

  • Acute Necrotizing Ulcerative Gingivitis (ANUG)

    • Associated with immunosuppression, poor oral hygiene, malnutrition, EtOH/tobacco-use

    • Commonly seen in younger patients and involves severe gingival disease

    • Present with dental/mouth pain, fevers

    • On exam expect halitosis, gingival bleeding, tooth mobility, lymphadenopathy

      • look for blunting of papillae between the teeth

      • also expect an ulcerated gingiva

    • Diagnosis is clinical

      • yet consider HIV testing

    • Management

      • Chlorhexidine mouthwash

      • Consider oral antibiotics if systemic symptoms are present

  • Acute HIV Infection

    • Symptoms typically develop 2-4 weeks after initial exposure

      • pharyngitis

      • fever

      • fatigue

      • also headache, rash

    • Yet 10-60% of patient may be asymptomatic

    • 65% will also not have LFT abnormalities

  • Subcutaneous Emphysema

    • Could occur in the setting of recent dental work

      • as 2nd & 3rd molars directly communicate with the submandibular space

      • especially if they perform a Valsalva maneuver following recent molar work

    • Typically need a period of observation

    • Followed by discharge on oral antibiotics

      • such as amox/clav

  • T-tube

    • This is a flexible, usually silicone, tracheal stent

      • Usually placed in the setting of tracheal stenosis

    • If patient presents in respiratory distress with T-tube in place:

      • first troubleshoot in place, including suction

      • if unsuccessful, can remove the T-tube using the external limb and proceed with intubation if needed

        • caution as T-tubes are commonly placed in the setting of tracheal stenosis

        • therefore beware of the indication prior to removing the T-tube and intubating from above


Orthopedic Trauma in a resource-limited setting WITH Dr. Bryant

  • Principles of Immobilization

    • Splint in a functional position

    • Splint like you mean it

      • always pad bony prominences

      • anticipate your splint staying on for a prolonged time, so avoid excess padding as it can make the splint loose and useless

  • Case #1

    • 8yo with closed forearm fracture with inability to follow-up due to cost and length of travel

    • Avoid fiberglass as family will not be able to self-remove it

    • Write a fracture passport on the splint

      • note the type of fracture, date of injury, date cast was placed, date to remove

    • Teach family how to self-remove the cast

      • typically with vinegar soak for >25mins followed by unrolling maneuver

      • can use strip of a rubber tire to protect the skin underneath

  • Case #2

    • 32yo F with open medial malleolus fracture s/p reduction who is unable to afford post-reduction x-ray

    • Antibiotics choice based on Gustilo-Anderson grading

      • Grade 1 or 2: cefazolin, clindamycin, fluoroquinolone (24 hours is typically enough)

      • Grade 3 or higher: antibiotics above, plus addition of gentamicin

    • Antibiotic choice also based on contamination

      • soil? PCN

      • freshwater? gentamicin

      • Saltwater? doxycycline

    • Consider a splint/cast window to allow direct monitoring

      • mainly used for fracture blisters and/or open wounds

      • yet takes away from the strength of the splint/cast

  • Case #3

    • 43yo with FOOSH injury and closed wrist deformity, yet no x-ray machine is available to you

    • Least likely injuries to need an x-ray in a resource-limiting setting?

      • wrist in extension

      • clavicle

      • tibial

      • pediatric forearm

    • Most likely injuries to need an x-ray?

      • hip

      • penetrating skull

      • ankle

      • elbow

      • possible proximal dislocation

      • foot with inability to angulate

    • Can rely on other tools, such as ultrasound instead

  • Case #4

    • 16yo on day 4 following a tibial fracture, who is walking on cast and leg now appears angulated again while still inside the cast and patient is unable to afford additional plaster/medications

    • Can open a wedge in the cast, near the fracture site, to correct the displacement manually again

  • Case #5

    • 25yo M with a closed mid-shaft femur fracture after being hit by a truck

    • Can use various sites for skeletal traction including

      • distal femur, proximal tibia

      • As well as calcaneus, distal tibia

    • Caution that pin site infections are relatively common

      • need to extensively clean area, start antibiotics

      • may need to remove pin and place another one elsewhere


Pharmacy Updates WITH Lesley Pahs & Nicole Harger Dykes

  • Euglycemic DKA

    • Definition

      • normal glucose (<250mg/dL)

      • metabolic acidosis (pH <7.3, bicarb <18mEq/L)

      • ketosis (preferably serum beta-hydroxybutyrate >3mmol/L)

    • Risk factors

      • SGLT2 inhibitor use

      • fasting state

      • ketogenic diet

      • intra-abdominal pathology (AGE, pancreatitis, etc.)

      • glycogen storage disease

      • infection, sepsis

      • intoxication/Ingestion (alcohol, cocaine)

      • chronic Liver disease

      • kidney disease

      • pregnancy

      • surgery

    • SGLT2 inhibitor pathophysiology

      • Na+/glucose co-transporter is inhibited

      • overall leading to an increase in ketogenesis and renal loss of bicarbonate

    • Clinical Presentation

      • Nausea, vomiting

      • Malaise, fatigue

      • In the setting of known EDKA risk factors such as SGLT2 inhibitor use

    • Treatment

      • Same as DKA

        • IVF, potassium, insulin/glucose

        • treat underlying cause including cessation of SGLT2 inhibitor

    • Other adverse reactions of SGLT-2 inhibitors

      • AKI, hyperkalemia, hypovolemia, bone fractures, infections (including UTI’s), hypersensitivity

  • Xa Inhibitor Reversal

    • Reversal options

      • Andexanet Alfa: aka Andexxa

        • only FDA-approved agent

        • acts as a decoy molecule and sequesters Xa inhibitors

        • administered as a bolus, plus 2-hour infusion (complex dosing based on which anti-Xa is being reversed and timing of last dose)

        • very expensive

        • exclusion considerations: GCS <7, patient expected to go for surgery for higher mortality hemorrhages, estimated mortality <1 month from any cause, ICH volume >60cc

        • adverse effects include a 10-18% risk of thrombosis (including DVT, stroke, acute MI, and PE)

      • 4-factor PCC

        • acts to replete clotting factors

          • includes factors II, VII, IX, X

          • competes with Xa inhibitor

        • compared to andexanet alfa

          • less risk of thrombosis

          • less expensive

        • no clear dosing regimen

          • typically given as 50 units/kg

          • yet more recent given as 25 units/kg

          • can also give as a flat dose of 2,000 units

    • Controversy remains over the best choice for Xa inhibitor reversal

      • prospective RCT study is currently in process comparing andexanet alfa to usual care

    • When to reverse?

      • patient on AC and remains pharmacologically active

        • rivaroxaban/edoxaban: last dose within 18 hours (or 24 hours if CrCl <50ml/min)

        • apixaban: last dose within 18 hours (or 24 hours if Scr >1.5mg/dL)

        • lab assessment with PT> 16s, anti-Xa level greater of equal to 0.5

      • use clinical judgement to assess bleeding risk and presence of significant blood loss, while also consider site of bleeding

      • discuss with pharmacist about appropriate reversal agent

  • Dexmedetomidine: aka Precedex

    • Selective alpha-2 agonist at the presynaptic membrane

      • prevents NE reuptake

      • leads to sedation, anxiolysis, and analgesia

    • Pharmacokinetics

      • onset in 5-10 minutes

      • lasts 1-2 hours

      • metabolized in the liver

    • Indications for use

      • agitation: schizophrenia or bipolar disorder

      • general anesthesia

      • sedation in mechanically-ventilated patients

        • no loading dose

        • continuous infusion: 0.2 to 1 mcg/kg/hour

      • procedural sedation

        • loading dose: 0.5-1 mcg/kg over 10 minutes

        • followed by continuous infusion: 0.2 to 1 mcg/kg/hour

        • can titrate to desired level of sedation

    • UC Health-specific policies

      • Do not use in patients receiving continuous neuromuscular blockade

      • Restricted to:

        • prevention in shivering in hypothermia protocol patients

        • to avoid intubation in patients requiring continuous sedation

        • facilitate planned extubation

        • failed sedation despite intermittent benzodiazepine or continuous propofol infusion

        • alongside benzodiazepines for treatment of alcohol-use disorder

          • this requires attending physician approval

        • sublingual film form can be used for agitation in the ED

    • Adverse effects

      • bradycardia, tachycardia

      • hypotension, hypertension

      • bradypnea, hypoxia, and respiratory depression

    • No absolute contraindications exist

    • Yet there are disease-related considerations

      • cardiovascular disease: may exacerbate underlying myocardial dysfunction

      • liver dysfunction: drug is metabolized through the liver

      • older patients: higher incidence of cardiovascular effects

  • Antibiogram update

    • Klebsiella aerogenes is becoming more resistant to ceftriaxone and pip/tazo

    • Escherichia coli is less sensitive to levofloxacin and ciprofloxacin, compared to cefazolin and ceftriaxone


Pediatric seizures WITH dr. sahai

  • Newborn seizures (0-28 days old)

    • Newborns are unique due to lack of myelination, presence of an overactive brainstem, and have a hyper-excitatory nervous system

      • therefore less likely to have classic generalized seizures

      • expect more subtle exam findings such as bicycling, sucking, lip smacking, roving eyes, staring, blinking, swimming movement

    • Mimics of newborn seizures include:

      • Sandifer- back arching, typically associated with a feed/laying flat/spit-up, and tends to resolve as GERD resolves

      • Benign Sleep Myoclonus- jerking movement only when sleeping that last 3-5 seconds

      • Jitteriness- normal gaze, no autonomic changes, worse with stimulus

      • Breath Holding- typically after a crying episode, become briefly tonic with associated color change

      • Opsoclonus- typically still need a neurology consult due to association with a primary neurological pathology, such as neuroblastoma, yet can also be benign

    • Common etiology of newborn seizures

      • meningitis/TORCH infections

      • electrolyte issues

      • hypoxic ischemic encephalopathy

      • ICH

      • cerebral dysgenesis/genetic

    • Treatment of newborn seizures

      • phenobarbital

        • 1st line

        • 20mg/kg load, followed by 10-20mg/kg second load

      • phenytoin

      • levetiracetam

      • midazolam

    • Treatment of concomitant newborn electrolyte issues

      • hypoglycemia: D10 2cc/kg bolus, followed by a drip in 1/2NS

      • hypocalcemia: Calcium gluconate 10% 2cc/kg over 10 minutes

      • hypomagnesemia: Magnesium 50mg/kg IV

    • Head US is 1st line imaging in neonates to assess for ICH

      • no definitive data on the role for CT

      • will need an MRI to assess for structural changes

  • Pediatrics Seizures (>29 days old)

    • Infantile Spasms

      • usually before 1st year of life

      • brief, symmetric sudden contractions of flexor and extensor groups

      • yet can be subtle with only neck flexion and upward eye movements

      • early treatment can help improve neuro-developmental outcomes

        • unique treatment w/ ACTH

    • Febrile Seizures (6 months to 5 years old + fever + no history of afebrile seizures)

      • Simple: <15m, non-focal, one episode in 24h

        • no role for EEG or head imaging

        • otherwise, routine fever work-up based on age, presentation, vaccination status

        • consider LP if AMS, meningeal signs, 6-12 months old with partial immunizations, or pretreatment with antibiotics prior to seizure

        • counseling parents

          • slight increase in future risk for a seizure compared to the general population, yet no difference in neurological outcomes

          • antipyretics do NOT increase risk of recurrence

          • vaccines are still safe to administer after a seizure

            • MMR has highest risk of seizure associated with it

            • usually within 1-2 weeks after the vaccine

    • Complex: >15m, may be focal, two or more episodes in 24h

      • no need for emergent EEG

      • most literature points to no need for emergent imaging unless focal neurological signs are noted

        • consider glucose level, metabolic panel, EKG, urine toxicology

        • for fever work-up consider CBC, BCx, UA, UCx, viral panel

      • LP should be considered if <12 months, febrile status epilepticus, mental status change, or meningeal signs

      • admission is not always need and work-up can be performed as an outpatient including EEG

    • Status Epilepticus (defined as persistent seizure activity or intermittent activity without return to baseline between episodes that last for more than 5 minutes)

      • Provoking factors

        • fever

        • recent illness

        • risk of malnutrition, feeding abnormalities

        • trauma

        • ingestion

        • recent vaccines

      • Management

        • 1st Line

          • Yes IV/IO access? Lorazepam IV

            • 0.1mg/kg IV over 2 mins (max of 4mg)

          • No IV/IO access? Midazolam IM

            • 0.2mg/kg for <13kg, 5mg for 13-40kg, 10mg for >40kg

        • 2nd Line if still seizing after 5 minutes

          • Levetiracetam

            • 60mg/kg over 5 mins (max 4.5g)

          • Other options: fosphenytoin, valproate

        • 3rd Line if still seizing after 10 minutes

          • Midazolam

            • 0.2mg/kg IV bolus

            • followed by 0.2mg/kg/hour infusion

    • Unprovoked/Afebrile Seizures

      • Various etiologies

        • genetic

        • metabolic

        • structural

        • autoimmune

        • idiopathic

      • Classified as

        • Generalized

        • Partial

          • Absence Seizures

            • “staring spells”

            • no post-ictal period

            • most spontaneously remit

          • Benign Rolandic Epilepsy

            • most frequently during sleep transitions

            • focal seizures with tonic or clonic activity often involving the face with paresthesia of 1 side of the lower face or tongue, drooling, and dysarthria

          • Juvenile Myoclonic Epilepsy (JME)

            • occurs most frequently during sleep-wake transitions

            • triggered by sleep deprivation

          • Myoclonic jerking

      • Work-up

        • while labs (glucose, electrolytes, etc.) are frequently obtained for first afebrile seizure, there is no evidence to support this

        • EEG can be arranged as an outpatient

        • consider emergent imaging post-ictal paralysis is not quickly resolving or there is a presence of AMS

        • those with focal onset seizures will need an elective MRI looking for structural issues

          • otherwise, no need for MRI for those with generalized seizures, normal development, and reassuring exam

        • counseling parents

          • roll the child onto his or her side, place nothing in the mouth, and time the seizure

          • showers recommended over baths

          • children can swim but under direct adult supervision

          • avoiding any heights or climbing

          • okay for vaccinations

          • driving:

            • Ohio: no specific length of time. Applicant must disclose condition

            • Kentucky: seizure free > 90 days and taking prescribed medication. Must present a physician’s statement.

          • AED’s can interfere with OCPs